KWALITY PHARMACEUTICALS L vs ZYDUS LIFESCIENCES LTD

A side-by-side comparison of KWALITY PHARMACEUTICALS L (KPL) and ZYDUS LIFESCIENCES LTD (ZYDUSLIFE) — valuation, profitability, growth, and financial health — to help you judge which is the stronger buy today.

The verdict

On the numbers, ZYDUS LIFESCIENCES LTD leads KPL vs ZYDUSLIFE on 8 of 14 metrics. See the breakdown below — the right pick still depends on your goals (value vs growth, risk appetite).

Valuation

How expensive each stock is relative to its earnings and book value. Lower usually means cheaper.

41.63
P/E ratio
22.83
8.58
P/B ratio
4.09
0.00%
Dividend yield
0.09%
₹64.91
EPS
₹50.09

Profitability

How efficiently each company turns capital and sales into profit. Higher is better.

22.80%
Return on equity
21.20%
24.00%
Return on capital
21.00%
24.00%
EBITDA margin
31.00%
13.32%
Net margin
18.87%

Growth

Three-year compounded growth. Faster-growing businesses can justify a higher valuation.

26.08%
Revenue CAGR (3Y)
16.35%
52.21%
Profit CAGR (3Y)
34.80%

Size & financial health

Scale and balance-sheet strength. Bigger revenue/profit and lower debt are generally safer.

₹2,812 Cr
Market cap
₹1.15L Cr
₹503 Cr
Revenue
₹27,148 Cr
₹67 Cr
Net profit
₹5,124 Cr
0.00
Debt / equity
0.46
KWALITY PHARMACEUTICALS L
  • + ["Company is expected to give good quarter", "Company has delivered good profit growth of 35.0% CAGR over last 5 years", "Company has a good return on equity (ROE) track record: 3 Years ROE 18.2%", "Company's median sales growth is 27.4% of last 10 years"]
  • ["Stock is trading at 8.13 times its book value", "Though the company is reporting repeated profits, it is not paying out dividend", "Company has high debtors of 203 days."]
ZYDUS LIFESCIENCES LTD
  • + ["Company has delivered good profit growth of 18.8% CAGR over last 5 years"]
KWALITY PHARMACEUTICALS L full analysis ZYDUS LIFESCIENCES LTD full analysis

This comparison is for informational purposes only and is not investment advice. Please consult a SEBI-registered advisor before investing.